1. Tesofensine (NS 2330)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00148512 (ClinicalTrials.gov)	March 2003	7/9/2005	A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS ...	A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Exploratory ...	Parkinson Disease	Drug: 1. Tesofensine (NS 2330)	Boehringer Ingelheim	NULL	Completed	42 Years	80 Years	Both	254	Phase 2	Austria;France;Germany;Netherlands;Spain;United Kingdom;El Salvador

First Previous1Next Last